Dr Torsten Haferlach of Munich Leukemia Laboratory (MLL) discusses their goal to sequence, by whole genome sequencing, 5,000 patients with different kinds of leukemias and lymphomas—ultimately understanding the baseline of the disease. Hear how they’re utilizing the flow cells and scalability of the NovaSeq™ 6000 System to expand their research further than before.

View related videos

• Regeneron: Scaling NGS to deliver more discoveries, faster 
• CZ Biohub: Conducting innovative experiments with NGS
• Introducing NovaSeq: The Next Era in Sequencing Starts Now 

View related webinars

• See the NovaSeq 6000 System in action 

View related information

• NovaSeq 6000 System 

Subscribe to the Illumina video channel

For Research Use Only. Not for use in diagnostic procedures.